Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis — Stella

Recruiting

Back to Prurigo Nodularis (PN) trials

Trial locations(1 site)

Netherlands

University Medical Center Utrecht, Utrecht, Utrecht

Key details

Sponsor

UMC Utrecht

Collaborators

Sanofi

Enrollment target

~40 participants

Started

June 2025

Primary completion

June 2028

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov